Annual report
4320.TEDINET S100PTO2
Period2021-10-01 → 2022-09-30
Filed2022-12-20
StandardJapan GAAP
ConsolidatedYes
Data checks24 of 24 passed
Key figures · 149
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥13.7bn | 2021-10-01 → 2022-09-30 | Cons. | Net sales |
| Revenue | ¥12.3bn | 2020-10-01 → 2021-09-30 | Cons. | Net sales |
| Revenue | ¥10.6bn | 2019-10-01 → 2020-09-30d | Cons. | Net sales (5-year summary) |
| Revenue | ¥11.7bn | 2018-10-01 → 2019-09-30d | Cons. | Net sales (5-year summary) |
| Revenue | ¥9.0bn | 2017-10-01 → 2018-09-30d | Cons. | Net sales (5-year summary) |
| Operating income | ¥1.0bn | 2021-10-01 → 2022-09-30 | Cons. | Operating income |
| Operating income | ¥879m | 2020-10-01 → 2021-09-30 | Cons. | Operating income |
| Ordinary income | ¥1.0bn | 2021-10-01 → 2022-09-30 | Cons. | Ordinary income |
| Ordinary income | ¥909m | 2020-10-01 → 2021-09-30 | Cons. | Ordinary income |
| Ordinary income | ¥453m | 2019-10-01 → 2020-09-30d | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥984m | 2018-10-01 → 2019-09-30d | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥590m | 2017-10-01 → 2018-09-30d | Cons. | Ordinary income loss (5-year summary) |
| Profit before tax | ¥1.1bn | 2021-10-01 → 2022-09-30 | Cons. | Income before income taxes |
| Profit before tax | ¥1.0bn | 2020-10-01 → 2021-09-30 | Cons. | Income before income taxes |
| Net income (owners) | ¥588m | 2021-10-01 → 2022-09-30 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥633m | 2020-10-01 → 2021-09-30 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥121m | 2019-10-01 → 2020-09-30d | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥532m | 2018-10-01 → 2019-09-30d | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥291m | 2017-10-01 → 2018-09-30d | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income | ¥683m | 2021-10-01 → 2022-09-30 | Cons. | Profit loss |
| Net income | ¥722m | 2020-10-01 → 2021-09-30 | Cons. | Profit loss |
| Total assets | ¥10.9bn | at 2022-09-30 | Cons. | Assets |
| Total assets | ¥9.5bn | at 2021-09-30 | Cons. | Assets |
| Total assets | ¥8.9bn | at 2020-09-30d | Cons. | Total assets (5-year summary) |
| Total assets | ¥7.8bn | at 2019-09-30d | Cons. | Total assets (5-year summary) |
| Total assets | ¥7.0bn | at 2018-09-30d | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥4.8bn | at 2022-09-30 | Cons. | Liabilities |
| Total liabilities | ¥4.0bn | at 2021-09-30 | Cons. | Liabilities |
| Net assets / equity | ¥6.1bn | at 2022-09-30 | Cons. | Net assets |
| Net assets / equity | ¥5.5bn | at 2021-09-30 | Cons. | Net assets |
| Net assets / equity | ¥4.8bn | at 2020-09-30d | Cons. | Net assets |
| Net assets / equity | ¥4.9bn | at 2019-09-30d | Cons. | Net assets (5-year summary) |
| Net assets / equity | ¥4.4bn | at 2018-09-30d | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥4.0bn | at 2022-09-30 | Cons. | Cash and deposits |
| Cash and deposits | ¥2.9bn | at 2021-09-30 | Cons. | Cash and deposits |
| Cash & equivalents | ¥4.0bn | at 2022-09-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥2.9bn | at 2021-09-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥2.8bn | at 2020-09-30d | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥1.4bn | at 2019-09-30d | Cons. | Cash and cash equivalents (5-year summary) |
| Cash & equivalents | ¥1.9bn | at 2018-09-30d | Cons. | Cash and cash equivalents (5-year summary) |
| Operating cash flow | ¥1.6bn | 2021-10-01 → 2022-09-30 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥1.0bn | 2020-10-01 → 2021-09-30 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥913m | 2019-10-01 → 2020-09-30d | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥324m | 2018-10-01 → 2019-09-30d | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥1.3bn | 2017-10-01 → 2018-09-30d | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Investing cash flow | −¥764m | 2021-10-01 → 2022-09-30 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥109m | 2020-10-01 → 2021-09-30 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥68m | 2019-10-01 → 2020-09-30d | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥493m | 2018-10-01 → 2019-09-30d | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥269m | 2017-10-01 → 2018-09-30d | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Financing cash flow | ¥307m | 2021-10-01 → 2022-09-30 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | −¥838m | 2020-10-01 → 2021-09-30 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | ¥574m | 2019-10-01 → 2020-09-30d | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥379m | 2018-10-01 → 2019-09-30d | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥258m | 2017-10-01 → 2018-09-30d | Cons. | Net cash provided by used in financing activities (5-year summary) |
| EPS (basic) | ¥39.13 | 2021-10-01 → 2022-09-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥42.34 | 2020-10-01 → 2021-09-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥8.1 | 2019-10-01 → 2020-09-30d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥35.26 | 2018-10-01 → 2019-09-30d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥20 | 2017-10-01 → 2018-09-30d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (diluted) | ¥8.09 | 2019-10-01 → 2020-09-30d | Cons. | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥35.13 | 2018-10-01 → 2019-09-30d | Cons. | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥19.47 | 2017-10-01 → 2018-09-30d | Cons. | Diluted earnings per share (5-year summary) |
| Net assets per share | ¥373.59 | at 2022-09-30 | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥339.05 | at 2021-09-30 | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥301.4 | at 2020-09-30d | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥301.83 | at 2019-09-30d | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥273.65 | at 2018-09-30d | Cons. | Net assets per share (5-year summary) |
| Equity ratio | 51.6% | at 2022-09-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 53.6% | at 2021-09-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 50.8% | at 2020-09-30d | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 58.4% | at 2019-09-30d | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 58.7% | at 2018-09-30d | Cons. | Equity to asset ratio (5-year summary) |
| ROE | 11.0% | 2021-10-01 → 2022-09-30 | Cons. | Rate of return on equity (5-year summary) |
| ROE | 13.2% | 2020-10-01 → 2021-09-30 | Cons. | Rate of return on equity (5-year summary) |
| ROE | 2.7% | 2019-10-01 → 2020-09-30d | Cons. | Rate of return on equity (5-year summary) |
| ROE | 12.3% | 2018-10-01 → 2019-09-30d | Cons. | Rate of return on equity (5-year summary) |
| ROE | 7.3% | 2017-10-01 → 2018-09-30d | Cons. | Rate of return on equity (5-year summary) |
| Employees | 593 | at 2022-09-30 | Cons. | Number of employees |
| Employees | 529 | at 2021-09-30 | Cons. | Number of employees |
| Employees | 529 | at 2020-09-30d | Cons. | Number of employees |
| Employees | 331 | at 2019-09-30d | Cons. | Number of employees |
| Employees | 315 | at 2018-09-30d | Cons. | Number of employees |
| Revenue | ¥547m | 2021-10-01 → 2022-09-30 | Standalone | Operating revenue1 |
| Revenue | ¥499m | 2020-10-01 → 2021-09-30 | Standalone | Operating revenue1 |
| Revenue | ¥529m | 2019-10-01 → 2020-09-30d | Standalone | Operating revenue1 (5-year summary) |
| Revenue | ¥351m | 2018-10-01 → 2019-09-30d | Standalone | Operating revenue1 (5-year summary) |
| Revenue | ¥343m | 2017-10-01 → 2018-09-30d | Standalone | Operating revenue1 (5-year summary) |
| Operating income | ¥148m | 2021-10-01 → 2022-09-30 | Standalone | Operating income |
| Operating income | ¥188m | 2020-10-01 → 2021-09-30 | Standalone | Operating income |
| Ordinary income | ¥151m | 2021-10-01 → 2022-09-30 | Standalone | Ordinary income |
| Ordinary income | ¥228m | 2020-10-01 → 2021-09-30 | Standalone | Ordinary income |
| Ordinary income | ¥231m | 2019-10-01 → 2020-09-30d | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | ¥58m | 2018-10-01 → 2019-09-30d | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | ¥95m | 2017-10-01 → 2018-09-30d | Standalone | Ordinary income loss (5-year summary) |
| Profit before tax | ¥146m | 2021-10-01 → 2022-09-30 | Standalone | Income before income taxes |
| Profit before tax | ¥141m | 2020-10-01 → 2021-09-30 | Standalone | Income before income taxes |
| Net income | ¥158m | 2021-10-01 → 2022-09-30 | Standalone | Profit loss |
| Net income | ¥143m | 2020-10-01 → 2021-09-30 | Standalone | Profit loss |
| Net income | ¥85m | 2019-10-01 → 2020-09-30d | Standalone | Net income loss (5-year summary) |
| Net income | ¥63m | 2018-10-01 → 2019-09-30d | Standalone | Net income loss (5-year summary) |
| Net income | ¥94m | 2017-10-01 → 2018-09-30d | Standalone | Net income loss (5-year summary) |
| Total assets | ¥5.2bn | at 2022-09-30 | Standalone | Assets |
| Total assets | ¥4.6bn | at 2021-09-30 | Standalone | Assets |
| Total assets | ¥5.0bn | at 2020-09-30d | Standalone | Total assets (5-year summary) |
| Total assets | ¥3.9bn | at 2019-09-30d | Standalone | Total assets (5-year summary) |
| Total assets | ¥4.2bn | at 2018-09-30d | Standalone | Total assets (5-year summary) |
| Total liabilities | ¥1.8bn | at 2022-09-30 | Standalone | Liabilities |
| Total liabilities | ¥1.3bn | at 2021-09-30 | Standalone | Liabilities |
| Net assets / equity | ¥3.3bn | at 2022-09-30 | Standalone | Net assets |
| Net assets / equity | ¥3.3bn | at 2021-09-30 | Standalone | Net assets |
| Net assets / equity | ¥3.2bn | at 2020-09-30d | Standalone | Net assets |
| Net assets / equity | ¥3.3bn | at 2019-09-30d | Standalone | Net assets (5-year summary) |
| Net assets / equity | ¥3.3bn | at 2018-09-30d | Standalone | Net assets (5-year summary) |
| Cash and deposits | ¥476m | at 2022-09-30 | Standalone | Cash and deposits |
| Cash and deposits | ¥866m | at 2021-09-30 | Standalone | Cash and deposits |
| EPS (basic) | ¥10.51 | 2021-10-01 → 2022-09-30 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥9.59 | 2020-10-01 → 2021-09-30 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥5.69 | 2019-10-01 → 2020-09-30d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥4.16 | 2018-10-01 → 2019-09-30d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥6.49 | 2017-10-01 → 2018-09-30d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (diluted) | ¥5.69 | 2019-10-01 → 2020-09-30d | Standalone | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥4.14 | 2018-10-01 → 2019-09-30d | Standalone | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥6.32 | 2017-10-01 → 2018-09-30d | Standalone | Diluted earnings per share (5-year summary) |
| Dividend per share | ¥12 | 2021-10-01 → 2022-09-30 | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥8 | 2020-10-01 → 2021-09-30 | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥6.8 | 2019-10-01 → 2020-09-30d | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥13.5 | 2018-10-01 → 2019-09-30d | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥12.5 | 2017-10-01 → 2018-09-30d | Standalone | Dividend paid per share (5-year summary) |
| Net assets per share | ¥220.8 | at 2022-09-30 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥218.05 | at 2021-09-30 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥212.89 | at 2020-09-30d | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥216.78 | at 2019-09-30d | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥219.48 | at 2018-09-30d | Standalone | Net assets per share (5-year summary) |
| Equity ratio | 64.4% | at 2022-09-30 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 71.1% | at 2021-09-30 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 64.1% | at 2020-09-30d | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 84.1% | at 2019-09-30d | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 79.3% | at 2018-09-30d | Standalone | Equity to asset ratio (5-year summary) |
| ROE | 4.8% | 2021-10-01 → 2022-09-30 | Standalone | Rate of return on equity (5-year summary) |
| ROE | 4.5% | 2020-10-01 → 2021-09-30 | Standalone | Rate of return on equity (5-year summary) |
| ROE | 2.6% | 2019-10-01 → 2020-09-30d | Standalone | Rate of return on equity (5-year summary) |
| ROE | 1.9% | 2018-10-01 → 2019-09-30d | Standalone | Rate of return on equity (5-year summary) |
| ROE | 2.9% | 2017-10-01 → 2018-09-30d | Standalone | Rate of return on equity (5-year summary) |
| Shares issued | 15,273,500 | at 2022-09-30 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 15,178,500 | at 2021-09-30 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 15,139,000 | at 2020-09-30d | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 7,553,400 | at 2019-09-30d | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 7,539,400 | at 2018-09-30d | Standalone | Total number of issued shares (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 21
| Segment | Item | Period | Value |
|---|---|---|---|
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue | 2021-10-01 → 2022-09-30 | ¥380m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue external | 2021-10-01 → 2022-09-30 | ¥380m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2021-10-01 → 2022-09-30 | −¥6m |
| Reconciling Itemsreconciling | segment profit | 2021-10-01 → 2022-09-30 | −¥111m |
| Medical Solution Businessreportable segment | employees | at 2022-09-30 | 502 pure |
| Medical Solution Businessreportable segment | revenue | 2021-10-01 → 2022-09-30 | ¥13.3bn |
| Medical Solution Businessreportable segment | revenue external | 2021-10-01 → 2022-09-30 | ¥13.3bn |
| Medical Solution Businessreportable segment | segment profit | 2021-10-01 → 2022-09-30 | ¥1.1bn |
| Total Of Reportable Segments And Otherssegment total | revenue | 2021-10-01 → 2022-09-30 | ¥13.7bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2021-10-01 → 2022-09-30 | ¥13.7bn |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2021-10-01 → 2022-09-30 | ¥1.1bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue | 2020-10-01 → 2021-09-30 | ¥152m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue external | 2020-10-01 → 2021-09-30 | ¥152m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2020-10-01 → 2021-09-30 | −¥12m |
| Reconciling Itemsreconciling | segment profit | 2020-10-01 → 2021-09-30 | ¥3m |
| Medical Solution Businessreportable segment | revenue | 2020-10-01 → 2021-09-30 | ¥12.1bn |
| Medical Solution Businessreportable segment | revenue external | 2020-10-01 → 2021-09-30 | ¥12.1bn |
| Medical Solution Businessreportable segment | segment profit | 2020-10-01 → 2021-09-30 | ¥888m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2020-10-01 → 2021-09-30 | ¥12.3bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2020-10-01 → 2021-09-30 | ¥12.3bn |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2020-10-01 → 2021-09-30 | ¥876m |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 1,322
| Item | Context | Value | Unit |
|---|---|---|---|
| Total shareholder return | CurrentYearInstant_NonConsolidatedMember | 1.665 | |
| Total return on share price index | Prior4YearInstant_NonConsolidatedMember | 1.108 | |
| Total return on share price index | Prior3YearInstant_NonConsolidatedMember | 0.993 | |
| Total return on share price index | Prior2YearInstant_NonConsolidatedMember | 1.042 | |
| Total return on share price index | Prior1YearInstant_NonConsolidatedMember | 1.329 | |
| Total return on share price index | CurrentYearInstant_NonConsolidatedMember | 1.234 | |
| Number of employees | CurrentYearInstant_jpcrp030000-asr_E05233-000MedicalSolutionBusinessReportableSegmentsMember | 502 | |
| Number of employees | CurrentYearInstant_OtherOperatingSegmentsAxisMember | 74 | |
| Number of employees | CurrentYearInstant_CorporateSharedMember | 17 | |
| Number of employees | CurrentYearInstant | 593 | |
| Research and development expenses research and development activities | CurrentYearDuration | 178000000 | JPY |
| Capital expenditures overview of capital expenditures etc | CurrentYearDuration_jpcrp030000-asr_E05233-000MedicalSolutionBusinessReportableSegmentsMember | 350632000 | JPY |
| Capital expenditures overview of capital expenditures etc | CurrentYearDuration_OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember | 293000 | JPY |
| Capital expenditures overview of capital expenditures etc | CurrentYearDuration_CorporateSharedMember | 1083267000 | JPY |
| Capital expenditures overview of capital expenditures etc | CurrentYearDuration | 1434193000 | JPY |
| Number of issued shares as of fiscal year end issued shares total number of shares etc | FilingDateInstant_OrdinaryShareMember | 15273500 | |
| Number of issued shares as of filing date issued shares total number of shares etc | FilingDateInstant_OrdinaryShareMember | 15273500 | |
| Number of issued shares as of fiscal year end issued shares total number of shares etc | FilingDateInstant | 15273500 | |
| Number of issued shares as of filing date issued shares total number of shares etc | FilingDateInstant | 15273500 | |
| Number of shares constituting one unit | CurrentYearInstant_OrdinaryShareMember | 100 | |
| Number of shareholders national and local governments | CurrentYearInstant_OrdinaryShareMember | － | |
| Number of shareholders financial institutions | CurrentYearInstant_OrdinaryShareMember | 12 | |
| Number of shareholders financial service providers | CurrentYearInstant_OrdinaryShareMember | 20 | |
| Number of shareholders other corporations | CurrentYearInstant_OrdinaryShareMember | 92 | |
| Number of shareholders foreign investors other than individuals | CurrentYearInstant_OrdinaryShareMember | 29 | |
| Number of shareholders foreign individual investors | CurrentYearInstant_OrdinaryShareMember | 25 | |
| Number of shareholders individuals and others | CurrentYearInstant_OrdinaryShareMember | 16386 | |
| Number of shareholders total | CurrentYearInstant_OrdinaryShareMember | 16564 | |
| Number of shares held number of units national and local governments | CurrentYearInstant_OrdinaryShareMember | － | |
| Number of shares held number of units financial institutions | CurrentYearInstant_OrdinaryShareMember | 16218 | |
| Number of shares held number of units financial service providers | CurrentYearInstant_OrdinaryShareMember | 2726 | |
| Number of shares held number of units other corporations | CurrentYearInstant_OrdinaryShareMember | 48789 | |
| Number of shares held number of units foreign investors other than individuals | CurrentYearInstant_OrdinaryShareMember | 4624 | |
| Number of shares held number of units foreign individual investors | CurrentYearInstant_OrdinaryShareMember | 46 | |
| Number of shares held number of units individuals and others | CurrentYearInstant_OrdinaryShareMember | 80296 | |
| Number of shares held number of units total | CurrentYearInstant_OrdinaryShareMember | 152699 | |
| Number of shares held shares less than one unit | CurrentYearInstant_OrdinaryShareMember | 3600 | |
| Percentage of shareholdings national and local governments | CurrentYearInstant_OrdinaryShareMember | － | |
| Percentage of shareholdings financial institutions | CurrentYearInstant_OrdinaryShareMember | 0.1062 | |
| Percentage of shareholdings financial service providers | CurrentYearInstant_OrdinaryShareMember | 0.0179 | |
| Percentage of shareholdings other corporations | CurrentYearInstant_OrdinaryShareMember | 0.3195 | |
| Percentage of shareholdings foreigners other than individuals | CurrentYearInstant_OrdinaryShareMember | 0.0303 | |
| Percentage of shareholdings foreign individuals | CurrentYearInstant_OrdinaryShareMember | 0.0003 | |
| Percentage of shareholdings individuals and others | CurrentYearInstant_OrdinaryShareMember | 0.5258 | |
| Number of shares held | CurrentYearInstant_No1MajorShareholdersMember | 1500100 | |
| Shareholding ratio | CurrentYearInstant_No1MajorShareholdersMember | 0.0996 | |
| Number of shares held | CurrentYearInstant_No2MajorShareholdersMember | 1200000 | |
| Shareholding ratio | CurrentYearInstant_No2MajorShareholdersMember | 0.0797 | |
| Number of shares held | CurrentYearInstant_No3MajorShareholdersMember | 1079600 | |
| Shareholding ratio | CurrentYearInstant_No3MajorShareholdersMember | 0.0717 |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 24 of 24 passed
| balance sheet identity | pass rounding |
| balance sheet identity | pass rounding |
| balance sheet identity | pass rounding |
| balance sheet identity | pass |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |